[Effects of combined aprotinin and prostagrandin E1 therapy on aortic arch replacement].
This study was undertaken to compare the effects of combined aprotinin and prostaglandin E1 therapy on aortic arch replacement. Twenty patients were divided into 2 groups with (group A; n = 10) or without (group B; n = 10) the treatment (200 KIU of aprotinin and 0.01-0.02 microgram/kg/min of prostaglandin E1 during cardiopulmonary bypass (CPB) and the first postoperative day. Preoperative evaluation of respiratory function and all parameters related to CPB procedure were revealed to be equal between the groups. Postoperative A-a DO2 and respiratory index (RI) as functional parameters of oxygenation capacity, dosage of dopamine were monitored at 0, 3, 6, 12, 18 and 24 hr after termination of CPB and at extubation period. Serum creatinine, platelet numbers and blood coagulation function (PT, APTT) were also assayed postoperatively. The recovery of respiratory and cardiac function were superior in group A with treatment, but renal and blood coagulation function showed no difference in the groups. We suggest the combined therapy with aprotinin and prostaglandin E1 for aortic arch replacement may emerge as a valuable treatment to save postoperative respiratory and cardiac function.
Kuraoka
S
S
Second Department of Surgergy, Yamagata University School of Medicine, Japan.
Orita
H
H
Watanabe
T
T
Abe
K
K
Abe
H
H
Inui
K
K
Iijima
Y
Y
Gotoh
S
S
Uchino
H
H
Murai
K
K
D000527:Alprostadil / Q000008:administration & dosage*; D001013:Aorta, Thoracic / Q000601:surgery*; D017545:Aortic Aneurysm, Thoracic / Q000503:physiopathology / Q000601:surgery; D007611:Aprotinin / Q000008:administration & dosage*; D001807:Blood Vessel Prosthesis; D002315:Cardiopulmonary Bypass; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care; D012119:Respiration
D007611:Aprotinin; D000527:Alprostadil